2022
DOI: 10.1186/s13071-021-05139-w
|View full text |Cite
|
Sign up to set email alerts
|

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

Abstract: Background A number of tick-borne pathogens circulate in the Belgian tick population in addition to the causative agent of Lyme borreliosis. However, so far, only a few patients with tick-borne diseases other than Lyme borreliosis have been reported in Belgium. The aim of this study was to investigate the occurrence of other human tick-borne infections in Belgium and their possible clinical manifestation. Methods Patients with fever (> 37.5 °C) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 59 publications
0
5
0
Order By: Relevance
“…One of the major obstacles to investigating how often and under what conditions Ca. N. mikurensis causes an infectious disease in humans, is its unequivocal detection in larger cohorts of patients with noncharacteristic disease symptoms [11,12] or in persons with a (recent) tick bite [13][14][15]. In other words, supportive laboratory diagnostics to detect and identify Ca.…”
Section: Introductionmentioning
confidence: 99%
“…One of the major obstacles to investigating how often and under what conditions Ca. N. mikurensis causes an infectious disease in humans, is its unequivocal detection in larger cohorts of patients with noncharacteristic disease symptoms [11,12] or in persons with a (recent) tick bite [13][14][15]. In other words, supportive laboratory diagnostics to detect and identify Ca.…”
Section: Introductionmentioning
confidence: 99%
“…However, due to the scarcity of confirmed patient material, such as blood samples and even DNA extracts of these rare TBD cases, the repeatability of the other targets could not be evaluated [32]. In addition, the occurrence of non-reproducible results [14] and the contamination of positive controls [32] should not be overlooked. Therefore, confirmation of positive test results for these rare diseases by independent (European) laboratories or by sequencing the PCR products is essential in making a reliable diagnosis, at least for the microorganisms that are not yet established as human pathogens or that do not occur regularly (e.g., Spiroplasma and Neoehrlichia).…”
Section: Discussionmentioning
confidence: 99%
“…Of important notice is that the detection of a microorganism is indicative of infection but not of disease causation and should be complemented by additional diagnostic modalities such as serology and, whenever possible, live culture [14]. An assay that could be of great added value next to the multiplex qPCRs is a multi-pathogen serological diagnostic assay for the combined antigen and antibody detection for multiple TBPs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This implies that MALDI-ToF MS is the method of choice for bacterial identification where >10 4 –10 5 cells are available for testing. In many cases, and this accounts not only for infections caused by fastidious organisms but for all human pathogens, even the best and most appropriate clinical specimens contain a very small number of pathogens (Geebelen et al 2022 ). This might result in false-negative diagnostic tests and this should always be considered in the interpretation of test results and the design of a therapeutic approach.…”
Section: More Complete and Innovative Diagnosticsmentioning
confidence: 99%